Upcoming Events

• May 14, 2009
  Development of Microparticulate Drug Delivery Systems for Clinical Trials
  
  Patrick P. DeLuca, PhD
  President, American Association of Pharmaceutical Scientists (AAPS)
  Professor, College of Pharmacy, University of Kentucky
  
  LOCATION:
  William Penn Inn
  Route 202 & Sumneytown Pike
  1017 DeKalb Pike
  Ambler PA 19002
  215-699-9272
  
  Details
  
  

Useful Links

PDE, A Pharmaceutical Trade Association
http://www.pdetrade.org/

Previous Events

• April 9, 2009
  Nanotechnology-based Drug Delivery: The First Step Towards Individualized Medicine?
  Patrick J. Sinko, Ph.D., RPh, Parke-Davis Professor of Pharmaceutics and Drug Delivery, Associate Vice President for Research, Rutgers University
  
  
• March 6, 2009
  Joseph B. Schwartz Memorial Symposium: Advances in Industrial Pharmacy
  Sponsored by the Philadelphia College of Pharmacy at University of the Sciences and the Philadelphia Pharmaceutical Forum
  Keynote speaker Robert E. O'Connor, Ph.D., vice president of product support at Cordis, a Johnson & Johnson company
  
  
• February 12, 2009
  Convergent Technologies and the Future of the Pharmaceutical Industry
  Theodore J. Torphy, Ph.D., Chief Scientific Officer & Head, External Research & Early Development, Johnson & Johnson Pharmaceuticals Group
  
  
• January 8, 2009
  The Future Pharmaceutical Scientists
  Karen Habucky, Ph.D.
  
  

• October 9, 2008
  Current challenges in dissolution testing including the role of QBD
  Vivian A. Gray, V. A. Gray Consulting, Inc., Hockessin, DE
  
  
• September 11, 2008
  A Novel Process to Replace Most Granulation Processes
  Dr. Ismat Ullah, Bristol-Myers Squibb Co.
  
  
• May 8, 2008
  Using Gamma Scintigraphy to Achieve Optimal Oral Drug Delivery in Early Drug Development
  John McDermott, Pharmaceutical Profiles
  
  
• April 10, 2008
  Tablet Film Coating and the Application of "Quality by Design" Initiatives
  Dr. Stuart C. Porter, International Specialty Products (ISP)
  
  
• March 13th, 2008
  Lipid Based Drug Delivery Systems and Enhanced Bioavailability Mechanisms and Potential
  Dr. Paul M. Bummer , College of Pharmacy, University of Kentucky
  
  
• February 14, 2008
  Next Generation Drug-device Combination Products
  Dr. Jonathon Zhao, Cordis Corporation, A Johnson and Johnson Company
  
  
• January 10, 2008
  Pharmacogenomics: a new approach to drug discovery and treatment
  Dr. Evgeny Krynetskiy, Temple University and the Jayne Haines Center for Pharmacogenomics and Drug Safety
  
  

• November 8, 2007
  Technology Transfer by Design: Using Lean Six Sigma and Quality by Design to Improve the Process
  Ronald D. Snee and William J. Reilly, Jr., Tunnell Consulting

• October 11, 2007
  Nanosizing for Oral Drug Delivery – Biopharmaceutical and Formulation Aspects
  Dr. Filippos Kesisoglou and Dr. Sunny Panmai, Merck Research Laboratories

• September 13, 2007
  Lipid Based Self Micro-Emulsifying Systems (SMEDDS): Applications, Excipient Selection, Formulation, and Characterization
  Jasmine Musakhanian, Gattefossé USA

• May 10, 2007
  A Pediatricians Perspective of Pharmacotherapeutic Trial Philosophy and Processes: Children as Subjects
  Dr. Andrew Mulberg, Mature Products Therapeutic Area

• April 8, 2007
  Making our Data Patterns Visible
  Dr. Anil Mennon, Sanofi-Aventis

• March 8, 2007
  A Pharma View of the CYPHER® Sirolimus-eluting Coronary Stent
  Dr. Cynthia Maryanoff, Cordis Corporation, J&J Company

• February 8, 2007
  Pseudolatex Coatings in Controlled Release
  Dr. Brian AC Carlin MRPharmS, MRSC CChem, FMC BioPolymer

• January 11, 2007
  Soluble Macromolecular Conjugates for Passive Tumor Targeting
  Dr. Clyde Ofner III, University of the Sciences in Philadelphia